Shareholders approve preferential share issue and higher Section 186(2) limits
Shareholders of Bharat Parenterals have approved both resolutions put to the Extraordinary General Meeting held on October 23, 2026.
By ScoutQuest · · 2 min read
- Votes in favour
- 4,879,194
- Votes against
- 0
- Votes in favour % of votes polled
- 100.0000%
What was decided
Two special resolutions were placed before shareholders at the Extraordinary General Meeting held on Friday, October 23, 2026, and both were passed with the requisite majority.
- Resolution 1: issuance of equity shares of the company on a preferential basis.
- Resolution 2: making investments, giving loans, guarantees and providing security in excess of the limits specified under Section 186(2) of the Companies Act, 2013.
What a preferential issue means
A preferential issue is a fresh issue of equity shares to a select set of investors, rather than to all shareholders in proportion to their holding. Shareholders had to approve it because it can change the shareholding pattern and dilute existing holders. This update records that the approval has been given; the terms of the issue are not set out here.
What the Section 186(2) approval means
Section 186 of the Companies Act, 2013 places a ceiling on how much a company can lend, invest, or give guarantees and security in connection with loans to other bodies corporate. Once the board's limit is crossed, shareholder approval by special resolution is required. Passing this resolution gives the company headroom to go beyond the ordinary limit.
How the votes went
The numbers below are for Resolution 1, as recorded in the scrutinizer's consolidated report.
- Votes in favour: 4,879,194
- Votes against: 0
- % of votes in favour on votes polled: 100.0000%
- % of votes polled on outstanding shares: 70.7954%
- Total shares held, across categories: 6,891,963
Category-wise, the Promoter and Promoter Group cast 4,630,473 votes in favour, Public - Non Institutions cast 248,721 votes in favour, and Public - Institutions polled nil. Resolution 2 recorded the same in-favour figure of 4,879,194 votes.
Participation
The cut-off date for voting was October 16, 2026, with 3,757 shareholders on record. There were 69 members who voted through remote e-voting, and 28 shareholders attended the meeting through video conferencing — 5 from the Promoter and Promoter Group and 23 from the public. The company also stated that the promoter/promoter group were not interested in the preferential issue resolution.
What shareholders may take away
- Both items on the agenda were cleared with a special resolution, meaning the threshold required for special resolutions was met.
- The preferential issue approval is a step towards raising equity capital from select investors; the identity of the allottees and the issue price are part of the transaction documents rather than this voting disclosure.
- The Section 186(2) approval widens the company's ability to deploy funds as loans, investments or guarantees.
- The scrutinizer's report and e-voting results have been placed on the company's website and on the NSDL e-voting website.
Perception
The outcome is a formal clearance of both proposals by shareholders, with all votes cast in favour. What it changes for the company on the ground depends on the eventual size, pricing and use of the preferential issue proceeds and on how the wider investment and guarantee headroom is used.
Also from Bharat Parenterals
Bharat Parenterals schedules Q2 & H1FY27 earnings conference call for October 30, 2026
24 Oct 2026
Board meeting on October 29 to consider and approve September quarter and half year results
24 Oct 2026
EGM summary: preferential equity issue and Section 186 limit approval among 2 special resolutions
23 Oct 2026
More numbers
- Total shareholders on record date3757
- Votes in favour of Resolution 14879194
- % of votes in favour on votes polled (Resolution 1)100.0000
- % of votes polled on outstanding shares (total)70.7954
- Total shares held, all categories6891963
- Promoter and Promoter Group votes in favour4630473
- Public - Non Institutions votes in favour248721
- Members who voted through remote e-voting69
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.